Refining method of tetanus toxoid
A technology of tetanus toxoid and refining method, which is applied in the field of preparation of tetanus toxoid, can solve problems such as inability to effectively separate TT monomer, and achieve the effect of improving immunogenicity and purity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] The present embodiment provides the refining method of tetanus toxoid, and it comprises the steps:
[0043] (a) prepare the tetanus toxoid stock solution to be purified:
[0044] In this embodiment, the tetanus toxoid stock solution prepared as follows is used as the tetanus toxoid before purification, and the Clostridium tetani strain is cultivated in a suitable medium to produce tetanus toxin, and the tetanus toxin is added Appropriate amount of formaldehyde solution, detoxified at a suitable temperature to produce tetanus toxoid, tetanus toxoid is ultrafiltered and ammonium sulfate precipitated to obtain refined tetanus toxoid, the refined tetanus toxoid is adjusted to a suitable pH and then sterilized and filtered Obtain the tetanus toxoid stock solution for the experiment.
[0045] The obtained tetanus toxoid stock solution was subjected to high-performance liquid chromatography analysis, wherein the high-performance liquid chromatography system was Agilent 1100Se...
Embodiment 2
[0057] The present embodiment adopts the method substantially identical with embodiment 1 to purify TT stoste, presses the same method test with embodiment 1, and in this stoste, tetanus toxoid monomer content is only 71.61%, dimer content is 25.77%, more The polymer content was 2.62%. Chromatography was carried out in the same manner as in Example 1. The eluents from the 6th to 14min TT monomers were combined, and the samples were tested in the same way as in Example 1 to test the purity of TT monomer after purification. HPLC such as image 3 Shown, the purity reaches 96.04%, and its yield is 48.62%. The dimer content was 3.96%. Polymer content was 0.
Embodiment 3
[0059] The present embodiment adopts the substantially same method as in Example 1 to purify the TT stock solution, and tests in the same method as in Example 1. In this stock solution, the tetanus toxoid monomer content is only 77.43%, and the dimer content is 19.37%. Body content is 3.20, through the same method as in Example 1, carry out chromatography, the eluate containing TT monomer collected at the 7th ~ 15min is combined, and the TT monomer content after sampling is tested by the same method as in Example 1, Its HPLC such as Figure 4 Shown, the purity reaches 97.36%, and its yield is 41.69%. The dimer content was 2.64%. Polymer content was 0.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com